Gordan Srkalovic

6PUBLICATIONS
54CO-AUTHORS
Molecular targetsAllergyHaematological tumoursRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2026
Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

|Sep 23, 2026
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.

|Apr 22, 2026
Temsirolimus in Patients With Solid Tumors With PIK3CA Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

|Feb 14, 2025
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry.

Sheila K Pierson, Joshua D Brandstadter, Drew A Torigian

|Nov 27, 2024
A Short Course of Standard Velcade/Dexamethasone Followed by Unlimited Weekly Maintenance Therapy Is an Effective Treatment in Relapsed/Refractory Multiple Myeloma.

Harini Acharya Gangur, Harsha Trivedi, UshaSree Chamarthy

|Jun 27, 2024
Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO.

Gordan Srkalovic, Sally Nijim, Maya Blanka Srkalovic

Pageof 1

Frequent Collaborators

2 joint publications

Elizabeth Garrett-Mayer

2 joint publications

Frits van Rhee

2 joint publications

Sheila K Pierson

2 joint publications

Joshua D Brandstadter